Your stack already captures the deal. DealTruth tells you what the evidence supports.
Your CRM, your recorder and your forecasting tools each capture something real about a deal. DealTruth reads the evidence inside all of it. It shows what is established, what is still uncertain, and where the deal needs attention.
Four things have to be true before a forecast is real. Three of them already happen.
Follow one deal through a quarter and the fourth becomes obvious.
Someone tests whether the deal is real
Every answer is already in the evidence. Reading it back is manual, so it happens on the deals someone thinks to ask about.
None of these tools was built to test whether a deal is qualified. They record what happened. They leave the judging to a manager, deal by deal. DealTruth does that read on every deal, every week, so a gap surfaces while there is still quarter left to act on it.
Four layers, four different questions.
Each of these answers something different about the same deal. DealTruth does not replace your revenue stack. It adds an independent view of what the deal evidence actually supports.
You keep every tool you already run. What you add is the one answer none of them was built to give, on every deal, every week: whether it is real.
One of these is what your CRM holds. The other is what the evidence supports.
Same company, same quarter, same amount. Only the reading changes.
The Economic Buyer has never joined a call. The CFO was named once, then nothing.
DealTruth doesn’t guess whether a deal is qualified. It looks for the evidence.
So a deal like this one is flagged while the quarter can still absorb it, rather than at the forecast call.
Test it against a deal you’re unsure about.
Bring one you think is healthy and one you’re worried about. DealTruth reads every call, email and meeting behind both, and shows you what the evidence actually supports.
- Bring two deals
One you are confident about, one you are not. A name and the history behind them is enough.
- DealTruth reads the evidence
DealTruth reads every call, email and meeting on both deals, against the full MEDDPICC picture.
- See what the evidence supports
What is established, what is still uncertain, and where each deal needs attention.